The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12917843.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recombinant activated factor VII (rFVIIa) was first used to control bleeding in haemophilia patients. More recently, it has been used to prevent severe bleeding in patients without pre-existing coagulopathy. We report a case where rFVIIa was used to successfully control postoperative bleeding in a patient undergoing suprarenal abdominal aortic aneurysm (AAA) repair.
Medical subject headings
- Aortic Aneurysm, Abdominal
- Blood Loss, Surgical
- Factor VIIa